Supplementary Table S3 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer

অনুরূপ উপাদানগুলি

• Supplementary Table S1 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
  অনুযায়ী: Sofie H. Tolmeijer (15313251)
  প্রকাশিত: (2025)
• Supplementary Table S2 from Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer
  অনুযায়ী: Sofie H. Tolmeijer (15313251)
  প্রকাশিত: (2025)
• Supplementary Data 2 from Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
  অনুযায়ী: Ismael Fernández-Miranda (15051932)
  প্রকাশিত: (2025)
• Supplementary Data S1 from Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer
  অনুযায়ী: Andrew A. Davis (15030032)
  প্রকাশিত: (2025)
• Supplementary Data 1 from Monitoring Sarcoma Response to Immune Checkpoint Inhibition and Local Cryotherapy with Circulating Tumor DNA Analysis
  অনুযায়ী: Nam Q. Bui (14958210)
  প্রকাশিত: (2025)